Kaufmann SH - Search Results

1

Phase I and pharmacologic trial of cytosine arabinoside with the selective checkpoint 1 inhibitor Sch 900776 in refractory acute leukemias.

Karp JE, Thomas BM, Greer JM, Sorge C, Gore SD, Pratz KW, Smith BD, Flatten KS, Peterson K, Schneider P, Mackey K, Freshwater T, Levis MJ, McDevitt MA, Carraway HE, Gladstone DE, Showel MM, Loechner S, Parry DA, Horowitz JA, Isaacs R, Kaufmann SH. Karp JE, et al. Among authors: kaufmann sh. Clin Cancer Res. 2012 Dec 15;18(24):6723-31. doi: 10.1158/1078-0432.CCR-12-2442. Epub 2012 Oct 23. Clin Cancer Res. 2012. PMID: 23092873 Free PMC article. Clinical Trial.

2

Phase I and pharmacologic study of topotecan: a novel topoisomerase I inhibitor.

Rowinsky EK, Grochow LB, Hendricks CB, Ettinger DS, Forastiere AA, Hurowitz LA, McGuire WP, Sartorius SE, Lubejko BG, Kaufmann SH, et al. Rowinsky EK, et al. Among authors: kaufmann sh. J Clin Oncol. 1992 Apr;10(4):647-56. doi: 10.1200/JCO.1992.10.4.647. J Clin Oncol. 1992. PMID: 1312588 Clinical Trial.

3

Expression of nuclear envelope lamins A and C in human myeloid leukemias.

Kaufmann SH. Kaufmann SH. Cancer Res. 1992 May 15;52(10):2847-53. Cancer Res. 1992. PMID: 1581898

4

Topoisomerase II levels during granulocytic maturation in vitro and in vivo.

Kaufmann SH, McLaughlin SJ, Kastan MB, Liu LF, Karp JE, Burke PJ. Kaufmann SH, et al. Cancer Res. 1991 Jul 1;51(13):3534-43. Cancer Res. 1991. PMID: 1647269

5

Increased expression of the multidrug resistance-associated protein gene in relapsed acute leukemia.

Schneider E, Cowan KH, Bader H, Toomey S, Schwartz GN, Karp JE, Burke PJ, Kaufmann SH. Schneider E, et al. Among authors: kaufmann sh. Blood. 1995 Jan 1;85(1):186-93. Blood. 1995. PMID: 7528566 Free article.

6

Phase I and pharmacologic studies of pyrazoloacridine, a novel DNA intercalating agent, on single-dosing and multiple-dosing schedules.

Rowinsky EK, Noe DA, Grochow LB, Sartorious SE, Bowling MK, Chen TL, Lubejko BG, Kaufmann SH, Donehower RC. Rowinsky EK, et al. Among authors: kaufmann sh. J Clin Oncol. 1995 Aug;13(8):1975-84. doi: 10.1200/JCO.1995.13.8.1975. J Clin Oncol. 1995. PMID: 7636538 Clinical Trial.

7

Changes in topoisomerase I levels and localization during myeloid maturation in vitro and in vivo.

Kaufmann SH, Charron M, Burke PJ, Karp JE. Kaufmann SH, et al. Cancer Res. 1995 Mar 15;55(6):1255-60. Cancer Res. 1995. PMID: 7882318

8

Topoisomerase II levels and drug sensitivity in adult acute myelogenous leukemia.

Kaufmann SH, Karp JE, Jones RJ, Miller CB, Schneider E, Zwelling LA, Cowan K, Wendel K, Burke PJ. Kaufmann SH, et al. Blood. 1994 Jan 15;83(2):517-30. Blood. 1994. PMID: 7904487 Free article.

9

Phase I and pharmacodynamic study of the topoisomerase I-inhibitor topotecan in patients with refractory acute leukemia.

Rowinsky EK, Adjei A, Donehower RC, Gore SD, Jones RJ, Burke PJ, Cheng YC, Grochow LB, Kaufmann SH. Rowinsky EK, et al. Among authors: kaufmann sh. J Clin Oncol. 1994 Oct;12(10):2193-203. doi: 10.1200/JCO.1994.12.10.2193. J Clin Oncol. 1994. PMID: 7931489 Clinical Trial.

10

Phase I and pharmacologic study of high doses of the topoisomerase I inhibitor topotecan with granulocyte colony-stimulating factor in patients with solid tumors.

Rowinsky EK, Grochow LB, Sartorius SE, Bowling MK, Kaufmann SH, Peereboom D, Donehower RC. Rowinsky EK, et al. Among authors: kaufmann sh. J Clin Oncol. 1996 Apr;14(4):1224-35. doi: 10.1200/JCO.1996.14.4.1224. J Clin Oncol. 1996. PMID: 8648378 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,208 results

Search Page

Filters